These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 27805438)
1. Measurement of cortisol concentration in the tears of horses and ponies with pituitary pars intermedia dysfunction. Hart KA; Kitchings KM; Kimura S; Norton NA; Myrna KE Am J Vet Res; 2016 Nov; 77(11):1236-1244. PubMed ID: 27805438 [TBL] [Abstract][Full Text] [Related]
2. Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction. Beech J; Boston R; Lindborg S J Vet Intern Med; 2011; 25(6):1431-8. PubMed ID: 22092639 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of plasma ACTH, alpha-melanocyte-stimulating hormone, and insulin concentrations during various photoperiods in clinically normal horses and ponies and those with pituitary pars intermedia dysfunction. Beech J; Boston RC; McFarlane D; Lindborg S J Am Vet Med Assoc; 2009 Sep; 235(6):715-22. PubMed ID: 19751169 [TBL] [Abstract][Full Text] [Related]
4. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia. Beech J; Boston R; Lindborg S; Russell GE J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045 [TBL] [Abstract][Full Text] [Related]
5. Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction. Copas VE; Durham AE Equine Vet J; 2012 Jul; 44(4):440-3. PubMed ID: 21848531 [TBL] [Abstract][Full Text] [Related]
6. Investigation of rhythms of secretion and repeatability of plasma adrenocorticotropic hormone concentrations in healthy horses and horses with pituitary pars intermedia dysfunction. Rendle DI; Litchfield E; Heller J; Hughes KJ Equine Vet J; 2014 Jan; 46(1):113-7. PubMed ID: 23742059 [TBL] [Abstract][Full Text] [Related]
7. Assessment of tissue-specific cortisol activity with regard to degeneration of the suspensory ligaments in horses with pituitary pars intermedia dysfunction. Hofberger SC; Gauff F; Thaller D; Morgan R; Keen JA; Licka TF Am J Vet Res; 2018 Feb; 79(2):199-210. PubMed ID: 29359976 [TBL] [Abstract][Full Text] [Related]
8. Cytokine dysregulation in aged horses and horses with pituitary pars intermedia dysfunction. McFarlane D; Holbrook TC J Vet Intern Med; 2008; 22(2):436-42. PubMed ID: 18371032 [TBL] [Abstract][Full Text] [Related]
9. Effect of Age, Season, Body Condition, and Endocrine Status on Serum Free Cortisol Fraction and Insulin Concentration in Horses. Hart KA; Wochele DM; Norton NA; McFarlane D; Wooldridge AA; Frank N J Vet Intern Med; 2016; 30(2):653-63. PubMed ID: 26860336 [TBL] [Abstract][Full Text] [Related]
10. Effects of pituitary pars intermedia dysfunction and Prascend (pergolide tablets) treatment on endocrine and immune function in horses. Miller AB; Loynachan AT; Bush HM; Hart KA; Barker VD; Campana-Emard AG; Grubbs ST; Adams AA Domest Anim Endocrinol; 2021 Jan; 74():106531. PubMed ID: 32942194 [TBL] [Abstract][Full Text] [Related]
11. Influence of season and pituitary pars intermedia dysfunction on hair cortisol concentration in horses. Banse HE; Getachew F; Levy M; Smits J Domest Anim Endocrinol; 2020 Jul; 72():106375. PubMed ID: 31431311 [TBL] [Abstract][Full Text] [Related]
12. Effects of advanced age and pituitary pars intermedia dysfunction on components of the acute phase reaction in horses. Zak A; Siwinska N; Elzinga S; Barker VD; Stefaniak T; Schanbacher BJ; Place NJ; Niedzwiedz A; Adams AA Domest Anim Endocrinol; 2020 Jul; 72():106476. PubMed ID: 32380311 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effects of age and pituitary pars intermedia dysfunction on corneal sensitivity in horses. Miller C; Utter ML; Beech J Am J Vet Res; 2013 Jul; 74(7):1030-5. PubMed ID: 23802675 [TBL] [Abstract][Full Text] [Related]
14. Dysregulation of Cortisol Metabolism in Equine Pituitary Pars Intermedia Dysfunction. Morgan RA; Keen JA; Homer N; Nixon M; McKinnon-Garvin AM; Moses-Williams JA; Davis SR; Hadoke PWF; Walker BR Endocrinology; 2018 Nov; 159(11):3791-3800. PubMed ID: 30289445 [TBL] [Abstract][Full Text] [Related]
15. Whole-body phenylalanine kinetics and skeletal muscle protein signaling in horses with pituitary pars intermedia dysfunction. Mastro LM; Adams AA; Urschel KL Am J Vet Res; 2014 Jul; 75(7):658-67. PubMed ID: 24959733 [TBL] [Abstract][Full Text] [Related]
16. Pituitary pars intermedia dysfunction does not necessarily impair insulin sensitivity in old horses. Mastro LM; Adams AA; Urschel KL Domest Anim Endocrinol; 2015 Jan; 50():14-25. PubMed ID: 25240230 [TBL] [Abstract][Full Text] [Related]
17. Circadian and circannual rhythms of cortisol, ACTH, and α-melanocyte-stimulating hormone in healthy horses. Cordero M; Brorsen BW; McFarlane D Domest Anim Endocrinol; 2012 Nov; 43(4):317-24. PubMed ID: 22717182 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of basal plasma α-melanocyte-stimulating hormone and adrenocorticotrophic hormone concentrations for the diagnosis of pituitary pars intermedia dysfunction from a population of aged horses. Mc Gowan TW; Pinchbeck GP; Mc Gowan CM Equine Vet J; 2013 Jan; 45(1):66-73. PubMed ID: 22563728 [TBL] [Abstract][Full Text] [Related]
19. Systemic and pituitary pars intermedia antioxidant capacity associated with pars intermedia oxidative stress and dysfunction in horses. McFarlane D; Cribb AE Am J Vet Res; 2005 Dec; 66(12):2065-72. PubMed ID: 16379648 [TBL] [Abstract][Full Text] [Related]
20. Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction. Miller MA; Pardo ID; Jackson LP; Moore GE; Sojka JE Vet Pathol; 2008 Jan; 45(1):26-38. PubMed ID: 18192571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]